Last 12 months
Inside the activity.
0 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 19, 2017 Filed Dec 21, 2017 22:16 UTC |
Hanson Bryan CDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 126,260 | $0.00 Strike: $121.26 | $0.00 |
DisclosureSEC source: 0000911916-17-000256 · edgar.xml · derivative · entry 1 Hanson Bryan C · CIK 0001524349 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,260 Underlying: Common Stock · 126,260 shares Expires 2027-12-19 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on December 19, 2018. F2 · derivative.expiration_date: This award will be forfeited in full if the reporting person fails to acquire in open-market purchases $3,000,000 of Zimmer Biomet Holdings, Inc. (the "Company") common stock within 90 business days of December 19, 2017. Read SEC document |
| December 12, 2017 Filed Feb 14, 2018 14:38 UTC |
Florin Daniel PSr. VP, CFO
|
GiftCommon Stock | 245 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-18-000027 · edgar.xml · nonDerivative · entry 1 Florin Daniel P · CIK 0001402459 · Sr. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,224 Read SEC document |
| November 29, 2017 Filed Dec 1, 2017 16:00 UTC |
Williamson Daniel E.Group President
|
SaleCommon Stock | 6,282 | $116.30 | $730,585.29 |
DisclosureSEC source: 0000911916-17-000246 · edgar.xml · nonDerivative · entry 1 Williamson Daniel E. · CIK 0001602430 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 F1 · price: Represents the sale of 6,282 shares in multiple transactions, ranging in price from $115.95 to $116.45 per share, resulting in a weighted average sale price of $116.2982. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Read SEC document |
| November 06, 2017 Filed Nov 7, 2017 19:27 UTC |
Florin Daniel PDirector · Interim CEO, Sr. VP, CFO
|
GiftCommon Stock | 255 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-17-000244 · edgar.xml · nonDerivative · entry 1 Florin Daniel P · CIK 0001402459 · Director · Interim CEO, Sr. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,469 F1 · balance_after: Includes 120 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan between June 30, 2017 and October 30, 2017. Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 13:44 UTC |
Farrell Michael J.Director
|
GrantPhantom Stock Units · Derivative | 204.266 | $0.00 Strike: $116.27 | $0.00 |
DisclosureSEC source: 0000911916-17-000239 · edgar.xml · derivative · entry 1 Farrell Michael J. · CIK 0001485164 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,070.554 Underlying: Common Stock · 204.266 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 102.133 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: 102.133 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 7.449 phantom stock units accrued on July 28, 2017 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 13:01 UTC |
Rhodes Jeffrey K.Director
|
GrantPhantom Stock Units · Derivative | 102.133 | $0.00 Strike: $116.27 | $0.00 |
DisclosureSEC source: 0000911916-17-000238 · edgar.xml · derivative · entry 1 Rhodes Jeffrey K. · CIK 0001560940 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,074.975 Underlying: Common Stock · 102.133 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 3.801 phantom stock units accrued on July 28, 2017 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 12:59 UTC |
MICHELSON MICHAEL WDirector
|
GrantPhantom Stock Units · Derivative | 204.266 | $0.00 Strike: $116.27 | $0.00 |
DisclosureSEC source: 0000911916-17-000237 · edgar.xml · derivative · entry 1 MICHELSON MICHAEL W · CIK 0001182415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,144.264 Underlying: Common Stock · 204.266 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 102.133 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: 102.133 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 5.665 phantom stock units accrued on July 28, 2017 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 12:56 UTC |
HIGGINS ARTHUR JDirector
|
GrantPhantom Stock Units · Derivative | 236.519 | $0.00 Strike: $116.27 | $0.00 |
DisclosureSEC source: 0000911916-17-000236 · edgar.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,719.929 Underlying: Common Stock · 236.519 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 39.467 phantom stock units accrued on July 28, 2017 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 12:55 UTC |
HAGEMANN ROBERTDirector
|
GrantPhantom Stock Units · Derivative | 247.269 | $0.00 Strike: $116.27 | $0.00 |
DisclosureSEC source: 0000911916-17-000235 · edgar.xml · derivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,099.243 Underlying: Common Stock · 247.269 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 30.543 phantom stock units accrued on July 28, 2017 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 12:50 UTC |
BOUDREAUX GAILDirector
|
GrantPhantom Stock Units · Derivative | 204.266 | $0.00 Strike: $116.27 | $0.00 |
DisclosureSEC source: 0000911916-17-000234 · edgar.xml · derivative · entry 1 BOUDREAUX GAIL · CIK 0001287920 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,154.329 Underlying: Common Stock · 204.266 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 13.391 phantom stock units accrued on July 28, 2017 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 12:48 UTC |
BERNARD BETSY JDirector
|
GrantPhantom Stock Units · Derivative | 236.519 | $0.00 Strike: $116.27 | $0.00 |
DisclosureSEC source: 0000911916-17-000233 · edgar.xml · derivative · entry 1 BERNARD BETSY J · CIK 0001166854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,740.225 Underlying: Common Stock · 236.519 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 16.385 phantom stock units accrued on July 28, 2017 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 12:47 UTC |
BEGLEY CHRISTOPHER BDirector
|
GrantPhantom Stock Units · Derivative | 204.266 | $0.00 Strike: $116.27 | $0.00 |
DisclosureSEC source: 0000911916-17-000232 · edgar.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,584.354 Underlying: Common Stock · 204.266 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 14.220 phantom stock units accrued on July 28, 2017 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 16:25 UTC |
Florin Daniel PDirector · Interim CEO, Sr. VP, CFO
|
GrantRestricted Stock Units · Derivative | 8,425 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-17-000223 · edgar.xml · derivative · entry 1 Florin Daniel P · CIK 0001402459 · Director · Interim CEO, Sr. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,425 Underlying: Common Stock · 8,425 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: Vests annually over two years in increments of 50% each year, commencing on August 1, 2018. F2 · derivative.expiration_date: Vests annually over two years in increments of 50% each year, commencing on August 1, 2018. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 20:35 UTC |
Collins Tony W.VP, Controller and CAO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,670 | $0.00 Strike: $104.01 | $0.00 |
DisclosureSEC source: 0000911916-17-000222 · edgar.xml · derivative · entry 14 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,010 Underlying: Common Stock · 2,670 shares Expires 2026-03-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: 2,670 options vested on March 21, 2017; and the remaining options will vest as to 2,670 options on each of March 21, 2018, 2019 and 2020. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 20:35 UTC |
Collins Tony W.VP, Controller and CAO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,723 | $0.00 Strike: $113.83 | $0.00 |
DisclosureSEC source: 0000911916-17-000222 · edgar.xml · derivative · entry 13 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,723 Underlying: Common Stock · 4,723 shares Expires 2025-06-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: 2,362 options vested on June 24, 2016; 2,361 options vested on June 24, 2017; and the remaining options will vest as to 2,362 options on June 24, 2018 and as to 2,361 options on June 24, 2019. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 20:35 UTC |
Collins Tony W.VP, Controller and CAO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,723 | $0.00 Strike: $113.83 | $0.00 |
DisclosureSEC source: 0000911916-17-000222 · edgar.xml · derivative · entry 12 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,722 Underlying: Common Stock · 4,723 shares Expires 2025-06-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 2,362 options vested on June 24, 2016; 2,361 options vested on June 24, 2017; and the remaining options will vest as to 2,361 options on each of June 24, 2018 and 2019. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 20:35 UTC |
Collins Tony W.VP, Controller and CAO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,428 | $0.00 Strike: $94.34 | $0.00 |
DisclosureSEC source: 0000911916-17-000222 · edgar.xml · derivative · entry 11 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,213 Underlying: Common Stock · 2,428 shares Expires 2024-03-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 1,214 options vested on each of March 17, 2016 and 2017; and the remaining 1,213 of the options are scheduled to vest on March 17, 2018. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 20:35 UTC |
Collins Tony W.VP, Controller and CAO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,752 | $0.00 Strike: $73.15 | $0.00 |
DisclosureSEC source: 0000911916-17-000222 · edgar.xml · derivative · entry 10 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,752 shares Expires 2023-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options vested on March 18, 2017. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 20:35 UTC |
Collins Tony W.VP, Controller and CAO
|
SaleCommon Stock | 597 | $121.32 | $72,428.04 |
DisclosureSEC source: 0000911916-17-000222 · edgar.xml · nonDerivative · entry 9 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 20:35 UTC |
Collins Tony W.VP, Controller and CAO
|
SaleCommon Stock | 93 | $121.76 | $11,323.69 |
DisclosureSEC source: 0000911916-17-000222 · edgar.xml · nonDerivative · entry 8 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 951 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 20:35 UTC |
Collins Tony W.VP, Controller and CAO
|
SaleCommon Stock | 1,200 | $122.38 | $146,855.04 |
DisclosureSEC source: 0000911916-17-000222 · edgar.xml · nonDerivative · entry 7 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,044 F3 · price: Represents the sale of 1,200 shares in multiple transactions ranging in price from $122.16 to $122.52 per share, resulting in a weighted average sale price of $122.3792. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 20:35 UTC |
Collins Tony W.VP, Controller and CAO
|
SaleCommon Stock | 15,096 | $121.71 | $1,837,326.61 |
DisclosureSEC source: 0000911916-17-000222 · edgar.xml · nonDerivative · entry 6 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,244 F2 · price: Represents the sale of 15,096 shares in multiple transactions ranging in price from $121.15 to $122.14 per share, resulting in a weighted average sale price of $121.7095. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 20:35 UTC |
Collins Tony W.VP, Controller and CAO
|
Exercise / conversionCommon Stock | 2,670 | $104.01 | $277,706.70 |
DisclosureSEC source: 0000911916-17-000222 · edgar.xml · nonDerivative · entry 5 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,340 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 20:35 UTC |
Collins Tony W.VP, Controller and CAO
|
Exercise / conversionCommon Stock | 4,723 | $113.83 | $537,619.09 |
DisclosureSEC source: 0000911916-17-000222 · edgar.xml · nonDerivative · entry 4 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,670 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 20:35 UTC |
Collins Tony W.VP, Controller and CAO
|
Exercise / conversionCommon Stock | 4,723 | $113.83 | $537,619.09 |
DisclosureSEC source: 0000911916-17-000222 · edgar.xml · nonDerivative · entry 3 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,947 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 20:35 UTC |
Collins Tony W.VP, Controller and CAO
|
Exercise / conversionCommon Stock | 2,428 | $94.34 | $229,057.52 |
DisclosureSEC source: 0000911916-17-000222 · edgar.xml · nonDerivative · entry 2 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,224 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 20:35 UTC |
Collins Tony W.VP, Controller and CAO
|
Exercise / conversionCommon Stock | 1,752 | $73.15 | $128,158.80 |
DisclosureSEC source: 0000911916-17-000222 · edgar.xml · nonDerivative · entry 1 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,796 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 120 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan between May 1, 2017 and June 30, 2017. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 19:55 UTC |
Rhodes Jeffrey K.Director
|
GrantPhantom Stock Units · Derivative | 92.477 | $0.00 Strike: $128.41 | $0.00 |
DisclosureSEC source: 0000911916-17-000215 · edgar.xml · derivative · entry 1 Rhodes Jeffrey K. · CIK 0001560940 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,969.041 Underlying: Common Stock · 92.477 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 19:55 UTC |
MICHELSON MICHAEL WDirector
|
GrantPhantom Stock Units · Derivative | 184.954 | $0.00 Strike: $128.41 | $0.00 |
DisclosureSEC source: 0000911916-17-000214 · edgar.xml · derivative · entry 1 MICHELSON MICHAEL W · CIK 0001182415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,934.333 Underlying: Common Stock · 184.954 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 92.477 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: 92.477 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 19:53 UTC |
HIGGINS ARTHUR JDirector
|
GrantPhantom Stock Units · Derivative | 208.317 | $0.00 Strike: $128.41 | $0.00 |
DisclosureSEC source: 0000911916-17-000213 · edgar.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,443.943 Underlying: Common Stock · 208.317 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 19:52 UTC |
HAGEMANN ROBERTDirector
|
GrantPhantom Stock Units · Derivative | 208.317 | $0.00 Strike: $128.41 | $0.00 |
DisclosureSEC source: 0000911916-17-000212 · edgar.xml · derivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,821.431 Underlying: Common Stock · 208.317 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 19:52 UTC |
Farrell Michael J.Director
|
GrantPhantom Stock Units · Derivative | 184.954 | $0.00 Strike: $128.41 | $0.00 |
DisclosureSEC source: 0000911916-17-000211 · edgar.xml · derivative · entry 1 Farrell Michael J. · CIK 0001485164 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,858.839 Underlying: Common Stock · 184.954 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 92.477 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: 92.477 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 19:50 UTC |
BOUDREAUX GAILDirector
|
GrantPhantom Stock Units · Derivative | 184.954 | $0.00 Strike: $128.41 | $0.00 |
DisclosureSEC source: 0000911916-17-000210 · edgar.xml · derivative · entry 1 BOUDREAUX GAIL · CIK 0001287920 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,936.672 Underlying: Common Stock · 184.954 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 19:50 UTC |
BERNARD BETSY JDirector
|
GrantPhantom Stock Units · Derivative | 208.317 | $0.00 Strike: $128.41 | $0.00 |
DisclosureSEC source: 0000911916-17-000209 · edgar.xml · derivative · entry 1 BERNARD BETSY J · CIK 0001166854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,487.321 Underlying: Common Stock · 208.317 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 19:49 UTC |
BEGLEY CHRISTOPHER BDirector
|
GrantPhantom Stock Units · Derivative | 184.954 | $0.00 Strike: $128.41 | $0.00 |
DisclosureSEC source: 0000911916-17-000208 · edgar.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,365.868 Underlying: Common Stock · 184.954 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| June 24, 2017 Filed Jun 27, 2017 17:37 UTC |
Williamson Daniel E.Group President
|
Exercise / conversionRestricted Stock Units · Derivative | 10,565 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-17-000199 · edgar.xml · derivative · entry 3 Williamson Daniel E. · CIK 0001602430 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,565 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F3 · derivative.exercise_date: The RSUs vested on June 24, 2017. F3 · derivative.expiration_date: The RSUs vested on June 24, 2017. Read SEC document |
| June 24, 2017 Filed Jun 27, 2017 17:37 UTC |
Williamson Daniel E.Group President
|
Tax withholdingCommon Stock | 4,283 | $129.26 | $553,599.17 |
DisclosureSEC source: 0000911916-17-000199 · edgar.xml · nonDerivative · entry 2 Williamson Daniel E. · CIK 0001602430 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,282 F1 · shares: Represents shares withled by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units. Read SEC document |
| June 24, 2017 Filed Jun 27, 2017 17:37 UTC |
Williamson Daniel E.Group President
|
Exercise / conversionCommon Stock | 10,565 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-17-000199 · edgar.xml · nonDerivative · entry 1 Williamson Daniel E. · CIK 0001602430 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,565 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2017 Filed Jun 27, 2017 17:36 UTC |
Johnson Adam RudolphGroup President
|
Exercise / conversionRestricted Stock Units · Derivative | 10,565 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-17-000198 · edgar.xml · derivative · entry 3 Johnson Adam Rudolph · CIK 0001557600 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,565 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F3 · derivative.exercise_date: The RSUs vested on June 24, 2017. F3 · derivative.expiration_date: The RSUs vested on June 24, 2017. Read SEC document |
| June 24, 2017 Filed Jun 27, 2017 17:36 UTC |
Johnson Adam RudolphGroup President
|
Tax withholdingCommon Stock | 3,489 | $129.26 | $450,970.70 |
DisclosureSEC source: 0000911916-17-000198 · edgar.xml · nonDerivative · entry 2 Johnson Adam Rudolph · CIK 0001557600 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,093 F1 · shares: Represents shares witheld by Zimmer Biomet Holdings, Inc. to satisfy tax witholding obligations on the vesting of restricted stock units. Read SEC document |
| June 24, 2017 Filed Jun 27, 2017 17:36 UTC |
Johnson Adam RudolphGroup President
|
Exercise / conversionCommon Stock | 10,565 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-17-000198 · edgar.xml · nonDerivative · entry 1 Johnson Adam Rudolph · CIK 0001557600 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,582 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2017 Filed Jun 27, 2017 17:35 UTC |
Florin Daniel PSr. VP, CFO
|
Exercise / conversionRestricted Stock Units · Derivative | 16,225 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-17-000197 · edgar.xml · derivative · entry 3 Florin Daniel P · CIK 0001402459 · Sr. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,225 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F4 · derivative.exercise_date: The RSUs vested on June 24, 2017. F4 · derivative.expiration_date: The RSUs vested on June 24, 2017. Read SEC document |
| June 24, 2017 Filed Jun 27, 2017 17:35 UTC |
Florin Daniel PSr. VP, CFO
|
Tax withholdingCommon Stock | 7,262 | $129.26 | $938,649.81 |
DisclosureSEC source: 0000911916-17-000197 · edgar.xml · nonDerivative · entry 2 Florin Daniel P · CIK 0001402459 · Sr. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,604 F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units. Read SEC document |
| June 24, 2017 Filed Jun 27, 2017 17:35 UTC |
Florin Daniel PSr. VP, CFO
|
Exercise / conversionCommon Stock | 16,225 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-17-000197 · edgar.xml · nonDerivative · entry 1 Florin Daniel P · CIK 0001402459 · Sr. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,866 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 226 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan between June 30, 2016 and May 1, 2017. Read SEC document |
| June 12, 2017 Filed Jun 13, 2017 21:20 UTC |
Yi SangPresident, Asia Pacific
|
SaleCommon Stock | 4,300 | $123.62 | $531,547.51 |
DisclosureSEC source: 0000911916-17-000192 · edgar.xml · nonDerivative · entry 8 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14 F5 · price: Represents the sale of 4,300 shares in multiple transactions ranging in price from $123.415 to $123.72 per share, resulting in a weighted average sale price of $123.6157. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 21:20 UTC |
Yi SangPresident, Asia Pacific
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,310 | $0.00 Strike: $94.34 | $0.00 |
DisclosureSEC source: 0000911916-17-000192 · edgar.xml · derivative · entry 11 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,655 Underlying: Common Stock · 3,310 shares Expires 2024-03-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: 1,655 options vested on each of March 17, 2016 and 2017; and the remaining 1,655 of the options are scheduled to vest on March 17, 2018. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 21:20 UTC |
Yi SangPresident, Asia Pacific
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,550 | $0.00 Strike: $74.90 | $0.00 |
DisclosureSEC source: 0000911916-17-000192 · edgar.xml · derivative · entry 10 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,550 shares Expires 2023-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: 1,775 options vested on each of April 1, 2016 and 2017. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 21:20 UTC |
Yi SangPresident, Asia Pacific
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,097 | $0.00 Strike: $73.15 | $0.00 |
DisclosureSEC source: 0000911916-17-000192 · edgar.xml · derivative · entry 9 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,097 shares Expires 2023-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 3,049 options vested on March 18, 2016; and 3,048 options vested on March 18, 2017. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 21:20 UTC |
Yi SangPresident, Asia Pacific
|
SaleCommon Stock | 474 | $124.93 | $59,216.87 |
DisclosureSEC source: 0000911916-17-000192 · edgar.xml · nonDerivative · entry 7 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,314 Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 21:20 UTC |
Yi SangPresident, Asia Pacific
|
SaleCommon Stock | 3,310 | $124.86 | $413,299.84 |
DisclosureSEC source: 0000911916-17-000192 · edgar.xml · nonDerivative · entry 6 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,788 F4 · price: Represents the sale of 3,310 shares in multiple transactions ranging in price from $124.42 to $125.30 per share, resulting in a weighted average sale price of $124.864. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.